Today: 3 June 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL shares fell 0.6% to A$153.27 Friday, ending a two-day rebound. The company disclosed a 69,497-share buyback for A$10.7 million and confirmed a new licensing deal with Eli Lilly for clazakizumab, including a $100 million upfront payment. Director Alison Watkins acquired 214 shares under a board plan. Investors are watching buyback pace and updates on the Lilly agreement next week.
20 February 2026
····
Westpac share price hits a fresh 52-week high as ASX banks run — CPI is the next big test

Westpac share price hits a fresh 52-week high as ASX banks run — CPI is the next big test

Westpac shares closed up 1.6% at A$42.54 on Friday, hitting a 52-week high and outperforming the S&P/ASX 200, which slipped 0.2%. The bank reported an unaudited Q1 net profit of A$1.9 billion last week, with its net interest margin down 3 basis points to 1.79%. Investors are watching next week’s inflation data for signals on rates. Australia’s jobless rate held at 4.1% in January.
20 February 2026
·
Compass Group share price nudges higher as investors eye dividend and April dollar trading switch

Compass Group share price nudges higher as investors eye dividend and April dollar trading switch

Compass Group shares rose 0.18% to 2,184 pence in early London trading Thursday, extending a rebound after a sharp early-February slide. The company will pay a dividend on Feb. 26 and switch to dollar trading on the London Stock Exchange on April 1. Investors remain cautious after concerns over AI’s impact on office catering. The stock remains below last year’s highs, with a 52-week range of 2,000 to 2,838 pence.
19 February 2026
··
GSK share price slips as Arexvy RSV data lands and stock goes ex-dividend

GSK share price slips as Arexvy RSV data lands and stock goes ex-dividend

GSK shares fell 0.4% in early London trading Thursday after the company released new real-world data on its RSV vaccine Arexvy and the stock went ex-dividend. A U.S. study linked Arexvy to reduced RSV-related hospitalisations and lower rates of major cardiovascular events in adults over 60. GSK also bought back 420,000 shares on Feb. 17. Investors await further RSV data and updates on dividends.
19 February 2026
····
British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running

British American Tobacco share price rises early as BAT reiterates 2026 outlook and keeps buyback running

British American Tobacco shares rose 1% to 4,389 pence in early London trading after the company reiterated it expects 2026 results at the lower end of guidance. BAT bought and plans to cancel nearly 99,000 shares as part of its ongoing buyback. The company highlighted growth in nicotine pouches and reaffirmed its push toward smokeless products. The FTSE 100 index was down 0.4% at the time.
19 February 2026
··
Meta doubles down on Nvidia with millions more AI chips — and a new CPU foothold

Meta doubles down on Nvidia with millions more AI chips — and a new CPU foothold

Meta will deploy millions of Nvidia Blackwell and Rubin GPUs, along with Grace CPUs and Spectrum-X networking, under an expanded multi-year partnership. Nvidia said Meta will use “confidential computing” for WhatsApp and build new AI data centers. Financial terms and delivery schedules were not disclosed. Nvidia shares rose 1.6%, Meta 0.6% after the announcement.
19 February 2026
···
1 … 13 14 15 16 17 … 586

Latest articles

Snap Lags Nasdaq, Turnaround Pressure Rises

Snap Lags Nasdaq, Turnaround Pressure Rises

3 June 2026
Snap Inc. shares slid 1.5% to $5.76 Tuesday—about 45% below last July’s high—even as the broader market rose, spotlighting investor doubts about Snap’s turnaround despite first-quarter revenue growth, narrowed losses, and major cost cuts; ad growth remains sluggish and the upcoming Specs update on June 16 is seen as a key test for future revenue momentum.
INFQ back on radar after UK quantum push; shares jump

INFQ back on radar after UK quantum push; shares jump

3 June 2026
Infleqtion shares surged 12.4% to $19.87 in late New York trading after announcing Gold Sponsorship of Quantum Fringe 2026 and new U.K. quantum partnerships, as investors bet on government contracts and expanded manufacturing, despite a $30.3 million quarterly net loss and warnings of ongoing operating losses if public-sector funding slows.
Corning shares move after AI news

Corning shares move after AI news

3 June 2026
Corning soared 13.4% to $200.40 on heavy volume after Nvidia’s CEO spotlighted the need for optical links in AI data centers, with Corning’s recent Nvidia and Meta deals making it a top play on AI infrastructure; first-quarter core sales jumped 18% and optical sales surged 36%, but investors face risks from consumer electronics demand and execution on new factory expansions.
Quantum computing stocks face a holiday week after IonQ stake filing and a Rigetti downgrade

IonQ Stock Jumped Again. A Giant Quantum IPO Is Putting the Trade on Trial

3 June 2026
IonQ shares closed up 3.1% at $71.40 before slipping 1.3% after hours as traders positioned ahead of Quantinuum’s upsized IPO, which seeks up to $1.46 billion at a $14.3 billion valuation; IonQ’s Q1 revenue surged 755% to $64.7 million with a raised 2026 outlook, but a $271.5 million operating loss and guidance for continued high expenses highlight risks as Wall Street awaits new sector benchmarks.
Xos Surges After Hours as Data-Center Power Play Hits Tape

Xos Surges After Hours as Data-Center Power Play Hits Tape

3 June 2026
Xos shares soared 135.8% to $5.26 in after-hours trading after launching a 2.5MWh Power Hub for data centers facing grid delays, but the company warned of "substantial doubt" about its ability to continue as a going concern, with just $9.8 million in cash at March 31 and no large orders yet announced for the new product.
Go toTop